The team will use this new capital to drive geographical expansion, expand its product portfolio and support regulatory clearances
SigTuple has raised Rs 34.5 crores ($4.3 million) in a fresh round of funding – led by existing investors Endiya Partners and Accel, with participation from a few strategic leaders from the healthcare sector. The team will use this new capital to drive geographical expansion, expand its product portfolio and support regulatory clearances.
Since 2020, the company has been laser focused on its core product (AI100), which is now getting traction in the Indian market. Over the last few months, SigTuple has onboarded 2 of the largest medical device distributors as channel partners for sales and service in India – Horiba Medical and Genworks Health. It has even expanded internationally in Indonesia, by onboarding one the largest local distributors in that country – Tawada Healthcare. Partnerships and product launches are also planned in other countries in SEA, MENA, Europe and the Americas.
Commenting on this, Tathagato Rai Dastidar Founder & CEO, SigTuple said, “The last 1 year has been truly transformative for the organisation – with major product improvements, new product additions and most importantly – strong customer traction. While we continue to build on the success of AI100 in India, 2023 is the year SigTuple will go global – with expansions planned across key markets in SEA, MENA, North America & Europe.”